Coexistence of T-Large Granular Lymphocyte Leukemia and Peripheral T Cell Lymphoma-NOS with indolent behaviour
Main Article Content
Keywords
PTCL-NOS, LGLL, Aggressive T-cell lymphomas, Indolent T-cell lymphomas
Abstract
T-cell lymphomas and leukemias are highly heterogeneous groups of rare disorders. We report a case of a 68-year-old man patient who develops two different T-cell neoplasms (Large Granular Lymphocyte Leukemia [LGLL] in 2018 and Peripheral T-cell non-Hodgkin lymphoma not otherwise specified [PTCL-NOS] in 2019) with a previous diagnosis of B-cell marginal zone lymphoma in 2010, treated with two lines of chemo-immunotherapy. The coexistence of these different T-cell neoplasms is rarely reported in literature and, moreover, is usually described as an LGLL transformation into PTCL-NOS; differently from these examples, herein the simultaneous conditions appear to be driven by different T-cell clones. Furthermore, the PTCL-NOS had a quite unusual behaviour, with a good disease control without intensive treatment. Because of these features, it could belong to a subgroup of indolent PTCL-NOS, not yet described in the WHO classification of T-cell neoplasms, which could benefit of less aggressive treatment.
Downloads
Abstract 847
PDF Downloads 437
HTML Downloads 198
References
[2] Pizzi M, Margolskee E, Inghirami G. Pathogenesis of Peripheral T Cell Lymphoma. Annual Review of Pathology: Mechanisms of Disease 2018. https://doi.org/10.1146/annurev-pathol-020117-043821.
[3] Lamy T, Moignet A, Loughran TP. LGL leukemia: From pathogenesis to treatment. Blood 2017. https://doi.org/10.1182/blood-2016-08-692590.
[4] Barilà G, Calabretto G, Teramo A, Vicenzetto C, Gasparini VR, Semenzato G, et al. T cell large granular lymphocyte leukemia and chronic NK lymphocytosis. Best Practice and Research: Clinical Haematology 2019. https://doi.org/10.1016/j.beha.2019.06.006.
[5] Teramo A, Barilà G, Calabretto G, Ercolin C, Lamy T, Moignet A, et al. STAT3 mutation impacts biological and clinical features of T-LGL leukemia. Oncotarget 2017. https://doi.org/10.18632/oncotarget.18711.
[6] Broccoli A, Zinzani PL. Peripheral T-cell lymphoma, not otherwise specified. Blood 2017. https://doi.org/10.1182/blood-2016-08-692566.
[7] Swerdlow SH, Campo E, Pileri SA, Lee Harris N, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016. https://doi.org/10.1182/blood-2016-01-643569.
[8] d’Amore F, Gaulard P, Trümper L, Corradini P, Kim WS, Specht L, et al. Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 2015. https://doi.org/10.1093/annonc/mdv201.
[9] Lee J, Park K, Kim KH, Bang HI, Yoon SY, Choi IH. Diagnostic challenges of indolent peripheral T cell lymphoma: A case report and literature review. Medicine 2020. https://doi.org/10.1097/MD.0000000000022657.
[10] Penn I. The role of immunosuppression in lymphoma formation. Springer Seminars in Immunopathology 1998. https://doi.org/10.1007/s002810050040.
[11] Nijland ML, Koens L, Pals ST, Ten Berge IJM, Bemelman FJ, Kersten MJ. Clinicopathological characteristics of T-cell non-Hodgkin lymphoma arising in patients with immunodeficiencies: A single-center case series of 25 patients and a review of the literature. Haematologica 2018. https://doi.org/10.3324/haematol.2017.169987.
[12] Savola P, Rajala H, Mustjoki S. LGL leukemia and autoimmunity - the borderline between autoimmune disease and cancer is becoming blurred. Duodecim; Laaketieteellinen Aikakauskirja 2016.
[13] Yoshida N, Nishikori M, Izumi T, Imaizumi Y, Sawayama Y, Niino D, et al. Primary peripheral T-cell lymphoma, not otherwise specified of the thyroid with autoimmune thyroiditis. British Journal of Haematology 2013. https://doi.org/10.1111/bjh.12255.
[14] Perry AM, Warnke RA, Hu Q, Gaulard P, Copie-Bergman C, Alkan S, et al. Indolent T-cell lymphoproliferative disease of the gastrointestinal tract. Blood 2013. https://doi.org/10.1182/blood-2013-07-512830.
[15] Matutes E, Wotherspoon AC, Parker NE, Osuji N, Isaacson PG, Catovsky D. Transformation of T-cell large granular lymphocyte leukaemia into a high-grade large T-cell lymphoma. British Journal of Haematology 2001. https://doi.org/10.1046/j.1365-2141.2001.03220.x.
[16] Belhadj M, Mansour D, Kaltenbach S, Deau-Fischer B, Franchi P, Tamburini J, et al. T-cell large granular lymphocyte leukemia transfomation into aggressive t-cell lymphoma: A report of two cases with molecular characterization. Haematologica 2019. https://doi.org/10.3324/haematol.2018.205542.
[17] Nakmaura N, Carreras J, Kikuti YY, Miyaoka M, Tomita S, Ishida F. RICHTER TRANSFORMATION OF T-CELL LARGE GRANULAR CELL LEUKEMIA. Hematological Oncology 2017. https://doi.org/10.1002/hon.2439_164.
[18] Hayashi E, Takata K, Sato Y, Tashiro Y, Tachiyama Y, Sawada-Kitamura S, et al. Distinct morphologic, phenotypic, and clinical-course characteristics of indolent peripheral T-cell lymphoma. Human Pathology 2013. https://doi.org/10.1016/j.humpath.2013.03.002.
Article Sidebar
Article Details
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers. Authors will grant copyright of their articles to the Institute of Hematology, Catholic University, Rome . No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.